A Safety and Efficacy Study in Subjects With Diabetic Neuropathic Pain
Public ClinicalTrials.gov record NCT00548925. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Global, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study Comparing the Safety and Efficacy of ABT-894 Versus Placebo in Subjects With Diabetic Neuropathic Pain
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to evaluate the safety and efficacy of a 6 mg twice a day dose of an investigational product in subjects with diabetic neuropathy
Study identification
- NCT ID
- NCT00548925
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 124 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 2007 (Type not available)
- Primary completion
- Dec 2008 (Actual)
- Completion
- Dec 2008 (Actual)
- Last update posted
- Jan 21, 2013
2007 – 2008
United States locations
- U.S. sites
- 12
- U.S. states
- 8
- U.S. cities
- 11
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Site Reference ID/Investigator# 6614 | Spring Valley | California | 91978 | — |
| Site Reference ID/Investigator# 6617 | Walnut Creek | California | 94598 | — |
| Site Reference ID/Investigator# 6356 | Hollywood | Florida | 33021 | — |
| Site Reference ID/Investigator# 6615 | Tampa | Florida | 33603 | — |
| Site Reference ID/Investigator# 6358 | Wellington | Florida | 33414 | — |
| Site Reference ID/Investigator# 6609 | St Louis | Missouri | 63141 | — |
| Site Reference ID/Investigator# 7229 | New Hyde Park | New York | 11042 | — |
| Site Reference ID/Investigator# 6618 | Charlotte | North Carolina | 28211 | — |
| Site Reference ID/Investigator# 6607 | Oklahoma City | Oklahoma | 73103 | — |
| Site Reference ID/Investigator# 6575 | Allentown | Pennsylvania | 18103 | — |
| Site Reference ID/Investigator# 8179 | San Antonio | Texas | 78229-4801 | — |
| Site Reference ID/Investigator# 6616 | San Antonio | Texas | 78229 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 17 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00548925, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 21, 2013 · Synced Oct 23, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00548925 live on ClinicalTrials.gov.